FY2024 EPS Estimates for Nyxoah S.A. (NASDAQ:NYXH) Lowered by Cantor Fitzgerald

Nyxoah S.A. (NASDAQ:NYXH) – Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for shares of Nyxoah in a note issued to investors on Wednesday, August 7th. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will earn ($1.98) per share for the year, down from their previous estimate of ($1.56). Cantor Fitzgerald has a “Overweight” rating and a $16.00 price objective on the stock. The consensus estimate for Nyxoah’s current full-year earnings is ($1.72) per share.

Nyxoah (NASDAQ:NYXH) last announced its earnings results on Tuesday, May 14th. The company reported ($0.45) EPS for the quarter, meeting analysts’ consensus estimates of ($0.45). Nyxoah had a negative net margin of 843.49% and a negative return on equity of 42.14%. The firm had revenue of $1.33 million for the quarter, compared to analysts’ expectations of $1.20 million.

Other research analysts have also issued research reports about the company. Oppenheimer reduced their price objective on Nyxoah from $15.00 to $13.00 and set an “outperform” rating for the company in a research report on Wednesday. HC Wainwright restated a “buy” rating and set a $18.00 price target on shares of Nyxoah in a report on Wednesday. Finally, Stifel Nicolaus cut their price objective on shares of Nyxoah from $27.00 to $19.00 and set a “buy” rating on the stock in a research report on Monday, June 24th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, Nyxoah presently has a consensus rating of “Buy” and an average target price of $17.20.

Nyxoah Price Performance

Shares of NASDAQ NYXH opened at $8.54 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 3.70 and a current ratio of 3.94. The company has a 50 day simple moving average of $8.34 and a two-hundred day simple moving average of $10.62. Nyxoah has a fifty-two week low of $4.00 and a fifty-two week high of $20.00. The company has a market capitalization of $212.99 million, a price-to-earnings ratio of -5.21 and a beta of 1.44.

Hedge Funds Weigh In On Nyxoah

A hedge fund recently bought a new stake in Nyxoah stock. Iron Triangle Partners LP acquired a new stake in shares of Nyxoah S.A. (NASDAQ:NYXH) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 253,025 shares of the company’s stock, valued at approximately $3,413,000. Nyxoah accounts for about 0.3% of Iron Triangle Partners LP’s investment portfolio, making the stock its 28th largest holding.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.